AdvancedMD Eylea Prior Authorization: Optimizing Anti-VEGF Workflows

Klivira streamlines AdvancedMD Eylea prior authorization, automating the complex process for anti-VEGF intravitreal injections and reducing administrative burden for specialty practices.

For ambulatory specialty practices managing conditions like wet AMD, diabetic macular edema, and retinal vein occlusion, efficient Eylea (aflibercept) prior authorization is critical for patient access and revenue integrity. The unique challenges of buy-and-bill medications, coupled with payer-specific requirements, necessitate a robust solution that integrates seamlessly with your AdvancedMD EHR.

Eylea Order Entry and Specialty Pharmacy Integration within AdvancedMD

Placing orders for Eylea (aflibercept) in AdvancedMD typically initiates a complex workflow, often involving specialty pharmacy coordination or buy-and-bill processes. Klivira integrates with AdvancedMD to capture these orders at the point of creation, ensuring that the prior authorization process begins immediately and accurately, routing necessary information to the appropriate channels, whether for direct dispensing or facility-administered drugs.

Navigating Medical vs. Pharmacy Benefit for Anti-VEGF in AdvancedMD

While some medications fall under pharmacy benefit, intravitreal injections like Eylea are predominantly covered under the medical benefit. Klivira's integration with AdvancedMD helps distinguish between these pathways, ensuring that the correct X12 278 transaction or ePA submission is initiated. This precision is vital for avoiding delays and denials associated with misrouted prior authorization requests within the AdvancedMD environment.

Critical Data Extraction for Eylea Prior Authorizations from AdvancedMD

Diagnosis codes (ICD-10) for wet AMD, diabetic macular edema, retinal vein occlusion.
Visual acuity measurements and historical trends.
Detailed physician notes outlining medical necessity and treatment plan.
Prior treatment history with other anti-VEGF agents or related therapies.
Retinal imaging reports, including OCT scans, supporting the diagnosis and progression.
Patient demographics and insurance information from the AdvancedMD record.

Klivira's Integration with AdvancedMD for Eylea Workflows

Klivira leverages the AdvancedMD API to establish a secure, bidirectional data exchange, pulling critical patient and clinical data directly from the EHR. This integration enables automated assembly of the prior authorization request, whether through X12 278 transactions, ePA portals, or Da Vinci PAS standards, ensuring all required fields for Eylea are populated accurately and efficiently.

Optimizing Anti-VEGF ePA Workflows in AdvancedMD for Specialty Practices

For practices heavily reliant on anti-VEGF therapies, automating the AdvancedMD Eylea prior authorization process significantly reduces administrative burden and improves operational efficiency. By streamlining the collection of clinical evidence and automating submission, Klivira helps minimize turnaround times, reduce denial rates, and ensure timely patient access to critical treatments for conditions like wet AMD and DME.

Frequently asked questions

How does Klivira identify Eylea orders within AdvancedMD to initiate prior authorization?

Klivira integrates directly with AdvancedMD's order entry system. When an Eylea (aflibercept) order is placed, our platform automatically detects it based on NDC or CPT codes, triggering the prior authorization workflow without requiring manual intervention from your staff.

What specific clinical data does Klivira extract from AdvancedMD for Eylea PAs?

Klivira pulls essential clinical documentation, including diagnosis codes (ICD-10), visual acuity, detailed physician notes, prior treatment history, and retinal imaging reports (e.g., OCT scans) directly from the AdvancedMD patient chart to support Eylea medical necessity.

Does Klivira handle both medical and pharmacy benefit prior authorizations for anti-VEGF drugs like Eylea?

Yes, Klivira supports both medical and pharmacy benefit prior authorizations. For Eylea, which is typically administered under the medical benefit, our system intelligently routes the request via the appropriate channels, such as X12 278 or payer-specific medical benefit portals.

How does Klivira integrate with AdvancedMD? Is it a SMART on FHIR integration?

Klivira integrates with AdvancedMD primarily through its robust API, ensuring secure and efficient data exchange. While AdvancedMD supports various integration methods, our approach focuses on reliable and comprehensive data extraction to power your prior authorization workflows.

Can Klivira assist with re-authorizations for ongoing Eylea treatments?

Absolutely. Klivira tracks authorization expiration dates and proactively initiates re-authorization workflows for ongoing Eylea treatments. This ensures continuous coverage and prevents treatment delays, leveraging updated clinical data from AdvancedMD as needed.